Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases—A pooled analysis of the German working group “stereotactic radiotherapy”

Lung Cancer - Tập 97 - Trang 51-58 - 2016
Juliane Rieber1,2, Jan Streblow1,2, Lorenz Uhlmann3, Michael Flentje4, Marciana Duma5, Iris Ernst6, Oliver Blanck7, Andrea Wittig8, Judit Boda-Heggemann9, Robert Krempien10, Fabian Lohaus11,12,13, Nathalie Desirée Klass14, Michael J. Eble15, Detlef Imhoff16, Henning Kahl17, Cordula Petersen18, Sabine Gerum19, Christoph Henkenberens20, Sonja Adebahr21, Peter Hass22
1Department of Radiation Oncology, University Hospital, Heidelberg, Germany
2Heidelberg Institute of Radiation Oncology, Germany
3Institute of Medical Biometry and Informatics, University of Heidelberg, Germany
4Department of Radiation Oncology, University Hospital Wuerzburg, Germany
5Department of Radiation Oncology, Technical University Munich, Germany
6Department of Radiation Oncology, University Hospital, Münster, Germany
7Department of Radiation Oncology, UKSH Universitätsklinikum Schleswig-Holstein, Kiel, Germany
8Department of Radiotherapy and Radiation Oncology, Philipps-University Marburg, University Hospital Giessen and Marburg, Germany
9Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Germany
10Department of Radiation Oncology, Helios Klinikum Berlin Buch, Germany
11Department of Radiation Oncology, Medical Faculty and University Hospital C.G. Carus, Technical University Dresden, Germany
12German Cancer Research Center (DKFZ), Heidelberg and German Cancer Consortium (DKTK) partner site Dresden, Germany
13OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany
14Department of Radiation Oncology, Bern University Hospital, Bern, Switzerland
15Department of Radiation Oncology, University Hospital Aachen, Germany
16Department of Radiation Oncology, University Hospital Frankfurt, Germany
17Department of Radiation Oncology, Hospital Augsburg, Germany
18Department of Radiation Oncology, University Hospital, Hamburg, Germany
19Department of Radiation Oncology, Ludwig Maximilians University, Munich, Germany
20Department of Radiotherapy and Special Oncology, Medical School Hannover, Germany
21Department of Radiation Oncology, University Hospital Freiburg, Germany
22Department of Radiation Oncology, University Hospital Magdeburg, Germany

Tài liệu tham khảo

Hellman, 1995, Oligometastases, J. Clin. Oncol., 13, 8, 10.1200/JCO.1995.13.1.8 Ashworth, 2013, Is there an oligometastatic state in non-small cell lung cancer: a systematic review of the literature, Lung Cancer, 82, 197, 10.1016/j.lungcan.2013.07.026 Badakhshi, 2013, Oligometastases the new paradigm and options for radiotherapy: a critical review, Strahlenther. Onkol., 189, 357, 10.1007/s00066-013-0326-1 Hanna, 2015, Stereotactic body radiotherapy for oligometastatic disease, Clin. Oncol. (R. Coll. Radiol.), 27, 290, 10.1016/j.clon.2015.02.003 Tree, 2013, Stereotactic body radiotherapy for oligometastases, Lancet Oncol., 14, e28, 10.1016/S1470-2045(12)70510-7 Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The international registry of lung metastases, J. Thorac. Cardiovasc. Surg., 1997, 113: 37–49. Adam, 2006, Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1452 patients and development of a prognostic model, Ann. Surg., 244, 524 Casiraghi, 2011, A 10-year single-center experience on 708 lung metastasectomies: the evidence of the international registry of lung metastases, J. Thorac. Oncol., 6, 1373, 10.1097/JTO.0b013e3182208e58 House, 2010, Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution, J. Am. Coll. Surg., 210, 744, 10.1016/j.jamcollsurg.2009.12.040 Pfannschmidt, 2007, Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series, Ann. Thorac. Surg., 84, 324, 10.1016/j.athoracsur.2007.02.093 Sterzing, 2014, Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO working group on stereotactic radiotherapy, Strahlenther. Onkol., 190, 872, 10.1007/s00066-014-0714-1 Grills, 2012, A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy, J. Thorac. Oncol., 7, 1382, 10.1097/JTO.0b013e318260e00d Guckenberger, 2013, Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis, J. Thorac. Oncol., 8, 1050, 10.1097/JTO.0b013e318293dc45 Boda-Heggemann, 2014, Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases, Radiat. Oncol., 9, 10, 10.1186/1748-717X-9-10 Baumann, 2009, Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy, J. Clin. Oncol., 27, 3290, 10.1200/JCO.2008.21.5681 Bral, 2011, Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial, Int. J. Radiat. Oncol. Biol. Phys., 80, 1343, 10.1016/j.ijrobp.2010.04.056 Fakiris, 2009, Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study, Int. J. Radiat. Oncol. Biol. Phys., 75, 677, 10.1016/j.ijrobp.2008.11.042 Ricardi, 2010, Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial, Lung Cancer, 68, 72, 10.1016/j.lungcan.2009.05.007 Timmerman, 2010, Stereotactic body radiation therapy for inoperable early stage lung cancer, JAMA, 303, 1070, 10.1001/jama.2010.261 Guckenberger, 2014, Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer, Strahlenther. Onkol., 190, 26, 10.1007/s00066-013-0450-y Corbin, 2013, Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy, J. Clin. Oncol., 31, 1384, 10.1200/JCO.2012.45.9651 Salama, 2015, Surgery or ablative radiotherapy for breast cancer oligometastases, Am. Soc. Clin. Oncol. Educ. Book, e8, 10.14694/EdBook_AM.2015.35.e8 Timmerman, 2006, Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer, J. Clin. Oncol., 24, 4833, 10.1200/JCO.2006.07.5937 Wood, 2008, How should variable selection be performed with multiply imputed data, Stat. Med., 27, 3227, 10.1002/sim.3177 Toutenburg, 1990, Multiple imputation for nonresponse in surveys, Stat. Papers, 31, 180, 10.1007/BF02924688 R Core Team, 2015 Guckenberger, 2015, Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy, Radiother. Oncol. Navarria, 2014, Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments, Radiat. Oncol., 9, 91, 10.1186/1748-717X-9-91 Ricardi, 2012, Stereotactic body radiation therapy for lung metastases, Lung Cancer, 75, 77, 10.1016/j.lungcan.2011.04.021 Singh, 2014, Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung, J. Thorac. Dis., 6, 369 Siva, 2010, Stereotactic radiotherapy for pulmonary oligometastases: a systematic review, J. Thorac. Oncol., 5, 1091, 10.1097/JTO.0b013e3181de7143 Guckenberger, 2014, Stereotactic body radiotherapy for stage I NSCLC: the challenge of evidence-based medicine, J. Thorac. Oncol., 9, e17, 10.1097/JTO.0000000000000080 Onishi, 2007, Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study, J. Thorac. Oncol., 2, S94, 10.1097/JTO.0b013e318074de34 Nuyttens, 2015, Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study, Int. J. Radiat. Oncol. Biol. Phys., 91, 337, 10.1016/j.ijrobp.2014.10.021 Kaifi, 2010, Indications and approach to surgical resection of lung metastases, J. Surg. Oncol., 102, 187, 10.1002/jso.21596 Shultz, 2014, Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer, J. Thorac. Oncol., 9, 1426, 10.1097/JTO.0000000000000317 Alongi, 2012, Review and uses of stereotactic body radiation therapy for oligometastases, Oncologist, 17, 1100, 10.1634/theoncologist.2012-0092 Milano, 2008, A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions, Cancer, 112, 650, 10.1002/cncr.23209 Milano, 2012, Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study, Int. J. Radiat. Oncol. Biol. Phys., 83, 878, 10.1016/j.ijrobp.2011.08.036 Ashworth, 2014, An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer, Clin. Lung Cancer, 15, 346, 10.1016/j.cllc.2014.04.003 Fode, 2015, Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases, Radiother. Oncol., 114, 155, 10.1016/j.radonc.2014.12.003 Pastorino, 1997, Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases, J. Thorac. Cardiovasc. Surg., 113, 37, 10.1016/S0022-5223(97)70397-0 Chang, 2015, Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials, Lancet Oncol., 16, 630, 10.1016/S1470-2045(15)70168-3 Widder, 2013, Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy, Radiother. Oncol., 107, 409, 10.1016/j.radonc.2013.05.024
Thông tin
Thông tin xuất bản

Lung Cancer

Tập 97

51-58

Thông tin tác giả